Bedside monitoring of infected pancreatic pockets
Part of Digestive system clinical trials.
This trial tests a special probe placed at the bedside to measure changes in the infected pocket of dead tissue in your pancreas. The goal is to see if the probe can help doctors better understand infection and guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed diagnosis of walled-off pancreatic necrosis (a pocket of dead tissue in the pancreas).
- There is a known or suspected infection in that pocket (for example, fever or high infection markers).
- Your doctor plans to drain the pocket with a needle through the skin as part of your regular care.
- You do not have a bleeding problem that cannot be fixed before the procedure (like very low platelets or high INR).
- You are not allergic to the materials used in the monitoring probe, and the probe can be safely placed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new freezing tool to remove dead tissue from the pancreas after acute pancreatitis. It might help you if you have a large, painful collection of dead tissue that needs to be cleaned out through a tube down your throat.
This study compares two ways to treat a pancreatic infection pocket (walled-off necrosis): removing dead/infected tissue right away versus starting with drainage and escalating if needed. It may help find the safest, most effective approach for getting the infection under control.
This trial uses a blood test to look for infection in people with a severe type of pancreatitis (inflammation of the pancreas). The goal is to see if the test can find infections faster and more accurately than current methods.
This trial collects blood samples from people with infected pancreatic necrosis to find patterns that help diagnose the condition. The goal is to reduce the need for invasive tests and start treatment faster.
This study looks at how tiny particles in blood (“exosomes”) carry signals between cells in people having pancreatic surgery. The goal is to understand these signals in different pancreatic conditions and treatment situations, which may help future care.
This trial tests a new device (Endorotor) against standard methods to clean out infected fluid collections in the pancreas after severe pancreatitis. It aims to see if the new approach works better and costs less.
Hear when a new Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.